Success Stories: NIW Approval for an Assistant Professor from China in the Field of Molecular Biology With the Help of Comprehensive Petition Drafted by Our Law Firm
Client’s Testimonial:
"The service provided by WeGreened is very helpful, it is a great time to work with them.”
On February 5th, 2020, we received another NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Assistant Professor
Country of Origin: China
State of Residence at the Time of Filing: Illinois
Approval Notice Date: February 5th, 2020
Processing Time: 5 months, 21 days
Case Summary:
North America Immigration Law Group (NAILG) helped an assistant professor from China acquire EB-2 NIW (National Interest Waiver) petition approval. Our client’s research focused on uncovering the pathogenesis of respiratory and cardiovascular diseases. We worked diligently to prove to the USCIS that our client’s research in his area is of great importance because it advances treatment development for acute respiratory syndrome. Therefore, his work has contributed significantly to the field of molecular biology, and his work, by advancing treatment options for acute respiratory syndrome, addresses an issue of global concern.
Drafting the Petition:
While preparing his NIW case, we looked at our client’s educational and professional qualifications and included what we learned in the petition packet drafted by us. We noted that he received a Ph.D. in biochemistry and molecular biology and had a B.S. in biological science. This was adjudged by the 507 citations accumulated from his 25 peer-reviewed scientific articles (10 of them first or co-first-authored) and 1 first-authored invited commentary.
Letters of Recommendation:
The NIW petition received a boost from the recommendation letters contributed by other distinguished experts in the field. These letters detailed our client’s academic achievements and research projects, and shed light on the highly urgent nature of his efforts in aiding the United States’ medical science sector. Endorsing our client’s continued stay in the country one recommender wrote: “[Client’s] work is highly important to the United States, as it has improved efforts to understand and treat pulmonary arterial hypertension… [Client’s] research is especially valuable because he has established a novel mouse model for researchers to understand how severe pulmonary arterial hypertension and right heart failure develop. Furthermore, his study has provided a strong tool to test drug candidates in this model before clinical trial. Overall, [client’s] research has provided novel targets for the prevention and treatment of pulmonary arterial hypertension.”
We are delighted that our efforts led to his NIW approval in less than 6 months. We congratulate our client on this milestone and thank him for choosing us to be a part of his success story.